We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MRC Technology, Alzheimer’s Association Collaborate

News   Jan 21, 2016

 
MRC Technology, Alzheimer’s Association Collaborate
 
 
 

RELATED ARTICLES

Novel ALS Therapy in Human Clinical Trials

News

A phase one/two clinical trial has launched to investigate whether a drug could benefit people with ALS whose disease is caused by mutations in a gene called SOD1

READ MORE

Chili Pepper Derived Anti-Obesity Drug Shows Promise in Animal Trials

News

A novel drug based on capsaicin, the compound that gives chili peppers their spicy burn, caused long term weight loss and improved metabolic health in mice eating a high fat diet.

READ MORE

Chemical Compound Class Possesses Potential for Treating Zika Virus

News

A new and promising class of chemical compounds has major potential for treating Zika virus and respiratory syncytial virus, or RSV, according to a new study.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE